VAFP
KALA icon

Vahanian & Associates Financial Planning’s KALA BIO KALA Stock Holding History

Vahanian & Associates Financial Planning’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-83
Closed -$46K – 63
2022
Q3 		$46K Buy
83
+10
+14% +$7.85K 0.16% 53
2022
Q2 		$54K Sell
73
-159
-69% -$249K 0.23% 37
2022
Q1 		$801K Sell
232
-187
-45% -$490K 1.85% 18
2021
Q4 		$1.27M Buy
+419
New +$1.94M 1.02% 22

Other funds holding KALA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vahanian & Associates Financial Planning's KALA Position: Q4 2022 in Review

Vahanian & Associates Financial Planning sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 83 shares — an estimated $46K sold.

Vahanian & Associates Financial Planning first reported a position in KALA in Q4 2021 and held it in 4 quarters. The position peaked at $1.27M in Q4 2021. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • Vahanian & Associates Financial Planning reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • Vahanian & Associates Financial Planning sold 83 KALA BIO shares in Q4 2022, an estimated $46K.
  • Vahanian & Associates Financial Planning first reported a position in KALA BIO in Q4 2021 and held it in 4 quarters.
  • Vahanian & Associates Financial Planning's KALA BIO position peaked at $1.27M in Q4 2021.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Vahanian & Associates Financial Planning's 13F filing for Q4 2022, filed 1 Feb 2023.